Imugene Ltd Total Liabilities

Latest as of December 2025: AU$25.80 Million AUD ≈ $18.26 Million USD

Imugene Ltd total liabilities. Based on the latest financial reports, Imugene Ltd (IMU) has total liabilities worth AU$25.80 Million AUD (≈ $18.26 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Imugene Ltd to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Imugene Ltd (1993–2025)

Total liabilities of Imugene Ltd from 1993 to 2025. This chart illustrates how Imugene Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Imugene Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.

Imugene Ltd Competitors by Total Liabilities

The table below lists competitors of Imugene Ltd ranked by their total liabilities.

Company Country Total Liabilities
Kingfish Company Nv
OL:KING
Norway Nkr122.14 Million
Netlinkz Ltd
AU:NET
Australia AU$28.13 Million
Active Biotech AB
ST:ACTI
Sweden Skr10.70 Million
NPK Co.Ltd
KQ:048830
Korea ₩23.33 Billion
HANHUA FNCL HLDG CO.H YC1
F:5HF
Germany €5.03 Billion
Huize Holding Ltd
NASDAQ:HUIZ
USA $506.32 Million
Bodhi Tree Multimedia Limited
NSE:BTML
India Rs817.62 Million
Goodyear Lastikleri TAS
IS:GOODY
Turkey TL12.32 Billion

Liability Composition Analysis (1993–2025)

This chart breaks down Imugene Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Imugene Ltd.

Liquidity & Leverage Metrics

Imugene Ltd Total Liabilities Ratios Explained

Imugene Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.78 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.77 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.62 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.38 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Imugene Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Imugene Ltd (1993–2025)

The table below shows the annual total liabilities of Imugene Ltd from 1993 to 2025.

Year Total Liabilities Change
2025-06-30 AU$38.56 Million
≈ $27.28 Million
+16.33%
2024-06-30 AU$33.14 Million
≈ $23.45 Million
+345.66%
2023-06-30 AU$7.44 Million
≈ $5.26 Million
-16.45%
2022-06-30 AU$8.90 Million
≈ $6.30 Million
+31.06%
2021-06-30 AU$6.79 Million
≈ $4.81 Million
+25.80%
2020-06-30 AU$5.40 Million
≈ $3.82 Million
+54.93%
2019-06-30 AU$3.48 Million
≈ $2.47 Million
+142.19%
2018-06-30 AU$1.44 Million
≈ $1.02 Million
+12.15%
2017-06-30 AU$1.28 Million
≈ $907.76K
-23.60%
2016-06-30 AU$1.68 Million
≈ $1.19 Million
+21.45%
2015-06-30 AU$1.38 Million
≈ $978.36K
-27.20%
2014-06-30 AU$1.90 Million
≈ $1.34 Million
+172.09%
2013-06-30 AU$698.03K
≈ $493.90K
+184.94%
2012-06-30 AU$244.97K
≈ $173.33K
-48.99%
2011-06-30 AU$480.28K
≈ $339.83K
+56.25%
2010-06-30 AU$307.37K
≈ $217.49K
-29.62%
2009-06-30 AU$436.72K
≈ $309.01K
-11.48%
2008-06-30 AU$493.37K
≈ $349.09K
-11.99%
2007-06-30 AU$560.55K
≈ $396.62K
-30.46%
2006-06-30 AU$806.04K
≈ $570.32K
+95.87%
2005-06-30 AU$411.52K
≈ $291.18K
-29.57%
2004-06-30 AU$584.29K
≈ $413.43K
-16.62%
2003-06-30 AU$700.77K
≈ $495.84K
+1259.15%
2002-06-30 AU$51.56K
≈ $36.48K
-98.07%
2001-06-30 AU$2.67 Million
≈ $1.89 Million
+195.33%
2000-06-30 AU$903.09K
≈ $638.99K
+0.57%
1999-06-30 AU$898.00K
≈ $635.39K
-20.95%
1998-06-30 AU$1.14 Million
≈ $803.79K
-8.46%
1997-06-30 AU$1.24 Million
≈ $878.09K
+10.12%
1996-06-30 AU$1.13 Million
≈ $797.42K
-13.64%
1995-06-30 AU$1.30 Million
≈ $923.37K
+927.56%
1994-06-30 AU$127.00K
≈ $89.86K
-78.36%
1993-06-30 AU$587.00K
≈ $415.34K
--

About Imugene Ltd

AU:IMU Australia Biotechnology
Market Cap
$11.63 Million
AU$16.44 Million AUD
Market Cap Rank
#26529 Global
#1198 in Australia
Share Price
AU$0.03
Change (1 day)
-2.94%
52-Week Range
AU$0.03 - AU$0.39
All Time High
AU$0.61
About

Imugene Limited, a clinical-stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumours in Australia. Its lead products under development azer-cel, an allogeneic CAR T cell therapy in phase 1 clinical trial targeting relapsed/refractory non-hodgkin lymphoma and b-cell acute lymphoblastic leukemia; CF33 VAXINIA,… Read more